Total
USD $0.00
 
Hong Kong

Company Overview of Sinopharm Group Company Limited (国药控股股份有限公司)

An EMIS Company Report EMIS is an ISI Emerging Markets Group Company Company Description

Sinopharm Group Company Limited is primarily engaged in the business of pharmaceutical distribution. The Group operates in three segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Group provides distribution, logistics and other value-added services for domestic and international manufacturers and other suppliers of pharmaceutical and healthcare products. The Group is also involved in the production and sale of pharmaceutical products, chemical reagents and laboratory supplies, and also the sale of medical equipment. The Group was incorporated in 2008 and is headquartered in Shanghai, China.

Need a report on this company? USD 29.95 Industry: Drugs and Druggists' Sundries Merchant Wholesalers Available in: English & Chinese Format: PDF Download Most recent financial data: 2017 Buy full report

Report contents

On purchasing the report for this company you will have access to a PDF containing the most recent data for Sinopharm Group Company Limited from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
NAICS Industry Classification
Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical and Medicine Manufacturing | Pharmacies and Drug Stores
Contact Information

Headquarters
27th Floor 01, Floor 27, 148 Electric Road, North Point, Hong Kong
Hong Kong; Hong Kong;

Tel: (86-21) 6321-
Fax: (86-21) 6321-

Email:
@sinopharmholding.com

Website:
http://www.sinopharmgroup.com.cn

Basic Information
Total Employees:
64,413 (2018)
Outstanding Shares:
Provided in the purchased report
Registered Capital:
Provided in the purchased report
Financial Auditors:
Provided in the purchased report
Incorporation Date:
October 06, 2008
Key Executives
Provided in the purchased report
Chairman and Executive Director
Provided in the purchased report
Non-Executive Director
Provided in the purchased report
Non-Executive Director
Provided in the purchased report
Non-Executive Director
Provided in the purchased report
Non-Executive Director
More
Ownership Details
China National Pharmaceutical Group Corporation
56.89%
OppenheimerFunds, Inc.
6.43%
Subsidiaries
Beijing Sinopharm Tianyuan Real Estate & Property Management Co., Ltd. (China)
100%
China National Pharmaceutical Group Shanghai Co., Ltd. (China)
100%
China National Pharmaceutical Group Shanghai Likang Medicine Co., Ltd. (China)
100%
More
M&A deals (Not included in report)

Report contents

On purchasing the report for this company you will have access to a PDF containing the most recent data for Sinopharm Group Company Limited from the EMIS database.

To give you a clear idea of the information provided, you can download a sample report for a different company below.

Download a sample report
Key Financial Highlights
Annual growth percentages* for latest two years in USD terms. Absolute financial data is included in the purchased report.
Net sales revenue
15.16%
Total operating revenue
15.16%
Operating profit (EBIT)
17.86%
EBITDA
18.05%
Net Profit (Loss) for the Period
7.45%
Total assets
13.1%
Total equity
14.32%
Operating Profit Margin (ROS)
0.11%
Net Profit Margin
-0.2%
Return on Equity (ROE)
-0.88%
Debt to Equity Ratio
-0.78%
Quick Ratio
-2.79%
Cash Ratio
0.8%
* Growth figures are affected by the currency rate changes.
Company News (Not included in report)
Industry News (Not included in report)
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

Request a demonstration of the EMIS service

To view more information, Request a demonstration of the EMIS service